A multicentre, double-blind, vehicle-controlled, randomised group-comparative study to evaluate the efficacy and safety of Altoderm™, a topically-applied sodium cromoglicate lotion, in the treatment of atopic dermatitis in children

Trial Profile

A multicentre, double-blind, vehicle-controlled, randomised group-comparative study to evaluate the efficacy and safety of Altoderm™, a topically-applied sodium cromoglicate lotion, in the treatment of atopic dermatitis in children

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jun 2016

At a glance

  • Drugs Sodium cromoglicate (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors Thornton & Ross
  • Most Recent Events

    • 31 Jul 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
    • 07 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top